KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Non Operating Income (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Non Operating Income for 17 consecutive years, with $28.6 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 45.92% to $28.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $90.3 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $90.3 million for FY2025, 0.0% changed from the prior year.
  • Non Operating Income for Q4 2025 was $28.6 million at Bio-Rad Laboratories, up from $8.3 million in the prior quarter.
  • The five-year high for Non Operating Income was $50.4 million in Q1 2023, with the low at -$600000.0 in Q3 2021.
  • Average Non Operating Income over 5 years is $17.9 million, with a median of $17.6 million recorded in 2021.
  • The sharpest move saw Non Operating Income tumbled 160.0% in 2021, then skyrocketed 6810.0% in 2022.
  • Over 5 years, Non Operating Income stood at $10.1 million in 2021, then tumbled by 77.23% to $2.3 million in 2022, then soared by 731.96% to $19.1 million in 2023, then increased by 2.43% to $19.6 million in 2024, then soared by 45.92% to $28.6 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $28.6 million, $8.3 million, and $16.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.